Chemoinformaics analysis of Ethyl nicotinate
| Molecular Weight | 151.165 | nRot | 2 |
| Heavy Atom Molecular Weight | 142.093 | nRig | 0 |
| Exact Molecular Weight | 151.063 | nRing | 1 |
| Solubility: LogS | -6.22 | nHRing | 1 |
| Solubility: LogP | 5.85 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 22.0651 |
| nHD | 0 | BPOL | 12.7729 |
| QED | 0.494 |
| Synth | 2.806 |
| Natural Product Likeliness | 1.189 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.358 |
| MDCK | 0.00000996 |
| BBB | 0.578 |
| PPB | 0.976929 |
| VDSS | 2.689 |
| FU | 0.0253223 |
| CYP1A2-inh | 0.642 |
| CYP1A2-sub | 0.752 |
| CYP2c19-inh | 0.423 |
| CYP2c19-sub | 0.908 |
| CYP2c9-inh | 0.487 |
| CYP2c9-sub | 0.714 |
| CYP2d6-inh | 0.026 |
| CYP2d6-sub | 0.065 |
| CYP3a4-inh | 0.349 |
| CYP3a4-sub | 0.312 |
| CL | 9.492 |
| T12 | 0.116 |
| hERG | 0.023 |
| Ames | 0.005 |
| ROA | 0.027 |
| SkinSen | 0.496 |
| Carcinogencity | 0.042 |
| EI | 0.987 |
| Respiratory | 0.102 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.891855 |